Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 13.3T | 13.5T | 12.8T | 12.6T |
Cost of revenue | 6.1T | 6.0T | 5.7T | 5.9T |
Gross profit | 10.3T | 10.5T | 9.9T | 9.7T |
Operating expense | ||||
Research & development | 2.0T | 1.9T | 1.8T | 1.8T |
Selling general and admin | 5.6T | 5.7T | 5.5T | 5.3T |
Other operating expenses | — | — | — | — |
Operating income | 2.7T | 2.9T | 2.6T | 2.6T |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -5.4B | -176.2B | -275.2B | -61.0B |
Pretax income | 2.7T | 2.7T | 2.4T | 2.5T |
Tax provision | 586.9B | 379.5B | 296.9B | 553.0B |
Net income | 2.1T | 2.3T | 2.1T | 1.9T |
Basic EPS | 1.6 | — | 1.6 | 1.5 |
Diluted EPS | 1.6 | — | 1.6 | 1.5 |
Basic average shares | 1.3T | — | 1.3T | 1.3T |
Diluted average shares | 1.3T | — | 1.3T | 1.3T |
EBITDA | 4.0T | 4.3T | 4.1T | 4.0T |
Net income from continuing op. | 2.1T | 2.3T | 2.1T | 1.9T |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |